PDE4D and familial pancreatic carcinoma: Given that PDE4D interacts with mTORC1 and promotes its activation by inhibiting PKA-mediated raptor phosphorylation at Ser-791, pharmacological inhibition of PDE4D by roflumilast or GEBR-7b suppresses pancreatic cancer cell growth in vitro and in vivo [16].